Rutgers, the State University of New Jersey

Anthrogenesis Corporation

Celularity Inc.

Marian Guelakis

Mohammad A Heidaran

Kristen S Labazzo

Prabhas V Moghe

Sascha Dawn Abramson

Shmuel Yaccoby

Ram Sharma

Provided herein are osteogenic placental adherent cells (OPACs), methods of using OPACs and OPAC populations, and methods of culturing, proliferating, expanding, or differentiating the OPACs. Further provided herein are methods of using the OPACs to formulate implantable or injectable compositions suitable for administration to a subject. Still further provided herein are methods for treating bone defects with OPACs and compositions comprising OPACs. Also provided herein are methods of using OPACs in the treatment and management of multiple myeloma, e.g., reducing the progression of, halting the progression of, or improving, one or more symptoms of multiple myeloma in an individual having multiple myeloma, comprising administering a plurality of OPACs to the individual.

Methods and compositions for treatment of bone defects with placental cell populations

Compositions, methods, and kits for repair and production of extracellular matrix are provided. In the broad aspect, the composition comprises a ligand of &#x3b1;5&#x3b2;1 integrin attached to a surface of a nanoparticle composed of a protein, with a proviso that the protein is not fibronectin.

Extracellular matrix production from nanoscale substrate

Growing community of inventors

Cranford, NJ, United States of America

Marian Guelakis